Search





Search





Markets
/
Stocks
/
cdna
/

CareDx Inc

CDNA

Add to Watchlist

37.332USD

-0.278-0.74%

Close 07-23 16:00（ET）Quotes delayed by 15 min

1.91BMarket Cap

LossP/E TTM

CareDx Inc

37.332

-0.278-0.74%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.74%

5 Days

-7.46%

1 Month

+48.61%

6 Months

+82.82%

Year to Date

+98.15%

1 Year

+184.54%

Key Figures

38.440Open

38.710High

392.00Volume

LossP/E TTM

33.61P/E Dynamic

--Dividend TTM

0.00%Turnover Ratio

37.610Prev. Close

37.385Low

14.72KTurnover

36.43P/E Static

6.11P/B

0.00%Div Yield TTM

-1.82%ROA

23.24052wk High

-0.00Volume Ratio

52.55MNet Profit

51.27MShares

-0.1585EPS TTM

2.49Beta

-2.36%ROE

10.96052wk Low

3.52%Amplitude

71.43%Gross Margin

1.91BMarket Cap

12.27Reward/Risk

3.15%Risk Rate

TradingKey Stock Score of CareDx Inc

Currency: USD Updated: 2026-07-23

Key Insights

CareDx Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 386 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 35.40.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CareDx Inc's Score

Industry at a Glance

Industry Ranking

3 / 386

Overall Ranking

17 / 4547

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

CareDx Inc Highlights

StrengthsRisks

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 35.49% year-on-year.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Undervalued

The company’s latest PE is -237.32, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 52.46M shares, decreasing 15.72% quarter-over-quarter.

Held by Catherine Wood

Star Investor Catherine Wood holds 1.75M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.15.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

35.400

Target Price

-8.15%

Upside Space

CareDx Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 7 analysts

Buy

Current Rating

35.400

Target Price

-8.15%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

495

Total

Median

Average

Company name

Ratings

Analysts

CareDx Inc

CDNA

Beigene Ltd

ONC

argenx SE

ARGX

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

Insmed Inc

INSM

...

Indicators

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

1.357

Buy

RSI(14)

72.176

Buy

STOCH(KDJ)(9,3,3)

80.079

Neutral

ATR(14)

2.088

High Vlolatility

CCI(14)

69.600

Neutral

Williams %R

21.749

Buy

TRIX(12,20)

1.812

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

38.406

Sell

MA10

34.832

Buy

MA20

31.762

Buy

MA50

26.281

Buy

MA100

22.576

Buy

MA200

20.261

Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

CareDx Inc Info

Ticker SymbolCDNA

CompanyCareDx Inc

CEOHanna (John W)

Websitehttps://www.caredx.com/

Shareholders

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

7.79%

Baron Capital Management, Inc.

6.11%

State Street Investment Management (US)

5.30%

ARK Investment Management LLC

4.31%

Deerfield Management Company, L.P.

4.24%

Other

72.25%

Popular Instruments

FAQs

What is the current price of CareDx Inc (CDNA)?



The current price of CareDx Inc (CDNA) is 37.61.

What is the symbol of CareDx Inc?



The ticker symbol of CareDx Inc is CDNA.

What is the 52-week high of CareDx Inc?



The 52-week high of CareDx Inc is 23.24.

What is the 52-week low of CareDx Inc?



The 52-week low of CareDx Inc is 10.96.

What is the market capitalization of CareDx Inc?



The market capitalization of CareDx Inc is 1.93B.

Is CareDx Inc (CDNA) currently rated as Buy, Hold, or Sell?



According to analysts, CareDx Inc (CDNA) has an overall rating of Buy, with a price target of 35.40.

What is the Earnings Per Share (EPS TTM) of CareDx Inc (CDNA)?



The Earnings Per Share (EPS TTM) of CareDx Inc (CDNA) is -0.40.